Results 171 to 180 of about 30,955 (215)

Randomised, double-masked trial to compare the efficacy, safety and immunogenicity of the biosimilar aflibercept FYB203 with reference aflibercept in patients with neovascular age-related macular degeneration. [PDF]

BMJ Open Ophthalmol
Balser S, Capsius B, Hole R, Papp A, Preissinger N, Rozenknop A, Tiko T.   +6 more
europepmc   +1 more source

Early Fluctuations of Exudative Lesions as Predictors of Two-Year Clinical Outcomes in Neovascular Age-Related Macular Degeneration. [PDF]

Transl Vis Sci Technol
Pu J, Zhuang X, Li M, Hao X, He G, Su Y, Xia L, Wen F.   +7 more
europepmc   +1 more source

Granzyme B contributes to subretinal fibrosis in neovascular age-related macular degeneration by modulating inflammation and epithelial-mesenchymal transition. [PDF]

J Neuroinflammation
Yoo HS, Chakravarthy H, Xi J, Cui J, Ai Z, Hosseini A, Song J, Tan N, Ma N, Zhou C, Li B, Bell R, Haegert A, Le Bihan S, Ju MJ, Granville DJ, Matsubara JA.   +16 more
europepmc   +1 more source

Clinical Features and Optical Coherence Tomography Angiography in Neovascular Age-Related Macular Degeneration and Pachychoroid Neovasculopathy. [PDF]

J Vitreoretin Dis
Khaohoen A, Chantarasorn Y.
europepmc   +1 more source

Clinical Characteristics and Long-Term Outcomes of Eyes With Neovascular Age-Related Macular Degeneration Requiring Frequent Treatment. [PDF]

J Vitreoretin Dis
Salabati M, Garrigan H, Momenaei B, Wakabayashi T, Wong JC, Patel D, Mahmoudzadeh R, Mansour HA, Ammar M, Xu D, Regillo CD.   +10 more
europepmc   +1 more source

One-Year Outcomes of Intravitreal Faricimab Injection in Treatment-Naïve Patients With Neovascular Age-Related Macular Degeneration. [PDF]

J Vitreoretin Dis
Okawa K, Maruyama-Inoue M, Chin JY, Inoue T, Yanagi Y, Kadonosono K.   +5 more
europepmc   +1 more source

Dysregulated serum lipid profiles in neovascular age-related macular degeneration revealed by UPLC‒MS/MS lipidomics. [PDF]

Lipids Health Dis
Qu Y, Liu Y, Fang J, Chen C, Cheng L, Xu X, Jin J, Chen X, Niu T, Wang H, Xing X, Shi X, Shen Y, Liu K.   +13 more
europepmc   +1 more source

Impact of Punctate Hyperfluorescence Status on Treatment Outcomes of Faricimab Versus Aflibercept in Neovascular Age-Related Macular Degeneration. [PDF]

J Clin Med
Kamao H, Goto K, Mizukawa K, Hiraki R, Miki A, Kimura S.   +5 more
europepmc   +1 more source

Vascular Endothelial Growth Factors in Eye Diseases. Pathophysiology and New Therapeutic Strategies for Retinal and Choroideal Angiogenesis (Verisuonikasvutekijöiden merkitys silmäsairauksissa. Patofysiologiaa ja uusia hoitomenetelmiä verkkokalvon ja suonikalvon angiogeneettisiin sairauksiin) [PDF]

Kinnunen, Kati
core  

Comparative Real-World Efficacy of Anti-Vascular Endothelial Growth Factor Agents in Neovascular Age-Related Macular Degeneration: A Multicenter Retrospective Study.

Ophthalmologica
Berco E, Kozlov Y, Ostrovsky M, Tuli R, Kin Man Lee T, Samocha K, Shcolnik E, Goldfeather Ben Zaken S, Shoham-Hazon N.   +8 more
europepmc   +1 more source